Aptamer-Targeted Attenuation of IL-2 Signaling in CD8+ T Cells Enhances Antitumor Immunity
Aptamer-Targeted Attenuation of IL-2 Signaling in CD8+ T Cells Enhances Antitumor Immunity …………… Rajagopalan A, Berezhnoy A, Schrand B, Puplampu-Dove Y, Gilboa E. Mol Ther. 2017 Jan 4;25(1):54-61. (also Aptamer, siRNA) PubMed 00